CABOCOL-01 trial: a single-arm phase II study assessing safety and efficacy of Cabozantinib for advanced or metastatic cervical carcinoma after platinum treatment failure
暂无分享,去创建一个
B. Clarisse | I. Licaj | F. Joly | J. Lequesne | A. Leconte | I. Bonnet | E. Coquan | P. Brachet | É. Meriaux | Anaïs Lelaidier | M. Castera